Seven House Democrats Demand IRS Issue 280E Cannabis Tax Guidance
Congressional letter pressures Treasury to clarify deduction rules amid ongoing Schedule III reclassification.

1040 tax forms with colorful 'Time to Pay Taxes' letters.
Congressional Pressure Mounts on IRS
Seven House Democrats formally requested that the IRS and Treasury Department issue clear guidance on Section 280E cannabis tax deductions, citing operational confusion and cash-flow strain on state-legal operators. The letter, dated May 29, 2026, follows months of regulatory silence since the DEA published its notice of proposed rulemaking to move cannabis to Schedule III.
Operators can't plan tax strategies or forecast cash needs. That's the lawmakers' core argument. Without clarity, cannabis businesses remain subject to 280E's prohibition on deducting ordinary business expenses—a tax burden that can exceed 70% of gross profits in high-tax states.
What 280E Does to Cannabis Operators
Section 280E bars businesses trafficking in Schedule I or II controlled substances from deducting rent, payroll, marketing, or any expense other than cost of goods sold. It's been the single largest tax liability for state-licensed cannabis companies since the early 2000s.
Rescheduling to Schedule III would eliminate 280E's application, but the DEA's rulemaking process has stretched into 2026 with no final rule published. Operators are caught in limbo: the proposed rule exists, yet compliance obligations remain tied to Schedule I, leaving companies to either overpay taxes under 280E or risk audit penalties by taking deductions prematurely.
Who Signed the Letter
The seven signatories represent districts with significant cannabis industries and have consistently supported federal reform legislation. While the letter doesn't name specific districts, the group includes members from California, Colorado, and Oregon, according to industry sources familiar with the correspondence.
Lawmakers requested that Treasury issue interim guidance by June 30, 2026. That would allow operators to begin taking deductions on a provisional basis pending finalization of the Schedule III rule.
What Happens Next
The cleanest read on this letter? It's a political signal, not a policy lever. The IRS has historically resisted issuing tax guidance in advance of final DEA scheduling actions, and Treasury's Office of Tax Policy isn't likely to move faster than the DEA's rulemaking timeline.
For full background on this story, see the CannIntel topic hub on 280E Tax Reform. Operators should continue filing under 280E rules until Treasury or the IRS publishes formal guidance or the DEA finalizes Schedule III reclassification.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
What is Section 280E?
Section 280E is a federal tax code provision that prohibits businesses trafficking in Schedule I or II controlled substances from deducting ordinary business expenses such as rent, payroll, or marketing. Only cost of goods sold can be deducted, resulting in effective tax rates that often exceed 70% of gross profit for state-legal cannabis operators.
Why are Democrats asking for guidance now?
The DEA proposed moving cannabis to Schedule III in 2024, but hasn't finalized the rule as of May 2026. Operators are stuck paying taxes under 280E rules while waiting for rescheduling to take effect. The lawmakers want interim guidance so businesses can begin taking deductions provisionally before the final rule is published.
Will the IRS issue interim guidance?
Unlikely. The IRS and Treasury Department have historically waited for final DEA scheduling decisions before issuing tax guidance. Issuing interim rules while the Schedule III proposal is still under review would create legal and procedural complications, making near-term relief improbable despite congressional pressure.
What should operators do in the meantime?
Continue filing tax returns under current 280E rules. Taking deductions prematurely, before Treasury or the IRS issues formal guidance or the DEA finalizes Schedule III reclassification, exposes operators to audit risk and potential penalties. Consult a cannabis-specialized CPA for jurisdiction-specific strategies.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Hawaii Denied 47 Gun Permits to Medical Marijuana Patients in 2025
Medical cannabis registration was the top reason Hawaii rejected firearm applications last year, state attorney general data shows.

Federal Medical Marijuana Recognition Raises Implementation Questions
Agencies face regulatory gaps after historic policy shift acknowledges medical value.

Minnesota Home Grow Rights Face Federal Threat Under DEA Rescheduling Rule
DEA's proposed Schedule III rule could override state law allowing home cultivation for medical patients.
More from the newsroom

Stale Flower Cuts Dispensary Margins as Aging Inventory Forces Discounts
Slow-moving cannabis flower forces retailers into margin-killing markdowns, turning freshness into a financial control point.

Opioid Overdoses Decline After Marijuana Legalization, NORML Analysis Finds
New data analysis links legal cannabis markets to measurable reductions in fatal opioid poisonings.

Pennsylvania House committee advances two adult-use cannabis bills
Health Committee approves cultivation and retail framework bills after months of closed-door negotiations.